Dr Maria T. Millan, president and CEO of the California Institute for Regenerative Medicine (CIRM), shares the Institute’s mission to advance basic and translational research in regenerative medicine in the State of California, their unique funding and operating model, and her perspective on the critical importance of investment in science and research.
The idea of CIRM was – and continues to be – the building of a regenerative medicine ecosystem in California for vital research opportunities to address unmet medical needs where traditional approaches and platforms have not succeeded
